[1] Goedert M, Spillantini M G. A century of Alzheimer's disease[J]. Science, 2006, 314(5800):777-781.
[2] 赵娟. BACE基因在阿尔兹海默症中作用机制的研究[D]. 北京:北京理工大学, 2008. Zhao Juan. Study on the mechanism of BACE gene in Alzheimer's disease[D]. Beijing:Beijing Institute of Technology, 2008.
[3] 赵丽波, 付宏娟, 张健莉. 阿尔茨海默病发生机制的研究进展[J]. 中国老年学杂志, 2011, 31(24):4997-4998. Zhao Libo, Fu Hongjuan, Zhang Jianli. Research progress on pathogene-sis of Alzheimer's disease[J]. Chinese Journal of Gerontology, 2011, 31(24):4997-4998.
[4] Viola K L, Velasco P T, Klein W L. Why Alzheimer's is a disease of mem-ory:The attack on synapses by A beta oligomers(ADDLs)[J]. The Journal of Nutrition Health and Aging, 2008,12(1):51S-57S.
[5] Choi S H, Kim Y H, Hebisch M, et al. A three-dimensional human neural cell culture model of Alzheimer/'s disease[J]. Nature, 2014, 515(7526):274-278.
[6] 王玲, 朱鸣峰. 阿尔茨海默病发病机制的研究进展[J]. 吉林医学, 2013, 34(3):531-532. Wang Ling, Zhu Mingfeng. Research Progress on pathogenesis of Alzheim-er's disease[J]. Jilin Medical Journal, 2013, 34(3):531-532.
[7] Sakono M, Zako T. Amyloid oligomers:Formation and toxicity of Abeta oligomers[J]. FEBS Journal, 2010, 277(6):1348-1358.
[8] 刘晓杰, 杨威, 祁金顺. 氧化应激与阿尔茨海默病[J]. 生理学报, 2012, 64(1):87-95. Liu Xiaojie, Yang Wei, Qi Jinshun. Oxidative stress and Alzheimer's dis-ease[J]. Acta Physiologica Sinica, 2012, 64(1):87-95.
[9] McGeer P L, Rogers J, McGeer E G. Inflammation, anti-inflammatory agents and Alzheimer disease:the last 12 years[J]. Journal of Alzheimer's Disease, 2006, 9(Suppl 3):271-276.
[10] McGeer E G, McGeer P L. Neuroinflammation in Alzheimer's disease and mild cognitive impairment:a field in its infancy[J]. Journal of Al-zheimer's Disease, 2010, 19(1):355-361.
[11] Sastre M, Walter J, Gentleman S M. Interactions between APP secretases and inflammatory mediators[J]. Journal of Neuroinflammation, 2008, 5(1):1.
[12] Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease[J]. Na-ture Reviews Neurology, 2011, 7(3):137-152.
[13] Jia Q, Deng Y, Qing H. Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid:insights from clinical trials[J]. BioMed Research International, 2014, 2014.
[14] Frölich L. Outcomes for clinical trials in mild-to-moderate dementia to evaluate drugs with presumably symptomatic effects[J]. The Journal of nutrition, Health & Aging, 2007, 11(4):357.
[15] Melnikova I. Therapies for Alzheimer's disease[J]. Nature Reviews Drug Discovery, 2007, 6(5):341-342.
[16] Wyss-Coray T. Inflammation in Alzheimer disease:Driving force, by-stander or beneficial response?[J]. Nature Medicine, 2006, 12(9):1005-1015.
[17] 蒋平, 孙秀佳, 向正华, 等. 丹参酮对于阿尔茨海默症大鼠颞叶iN-OS, MMP-2表达的影响及机理研究[J]. 现代生物医学进展, 2014, 14(18):3401-3404. Jiang Ping, Sun Xiujia, Xiang Zhenghua et al. The effect of tanshinone on the expression of iNOS, MMP-2 in temporal of Alzheimer's disease model rats and study on mechanism[J]. Progress in Modern Biomedicine, 2014, 14(18):3401-3404.
[18] 解双陆, 柳文媛. 抑肝散对神经系统疾病作用的研究进展[J]. 今日药学, 2013(3):181-185. Xie Shuanglu, Liu Wenyuan. Research progress on the effect of anti liv-er powder on nervous system diseases[J]. Pharmacy Today, 2013(3):181-185.
[19] Tateno M, Ukai W, Ono T, et al. Neuroprotective effects of Yi-Gan San against beta amyloid-induced cytotoxicity on rat cortical neurons[J]. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008, 32(7):1704-1707.
[20] Fujiwara H, Takayama S, Iwasaki K, et al. Yokukansan, a traditional Jap-anese medicine, ameliorates memory disturbance and abnormal social in-teraction with anti-aggregation effect of cerebral amyloid β proteins in amyloid precursor protein transgenic mice[J]. Neuroscience, 2011, 180:305-313.
[21] 张杰, 谢映红. 独活对痴呆大鼠脑组织中炎性细胞因子的影响[J]. 中医药学报, 2015, 43(1):27-29. Zhang Jie, Xie Yinghong. Effect of Angelica on inflammatory cytokines in the brain tissue of rats with dementia[J]. Acta Chinese Medicine and Pharmacology, 2015, 43(1):27-29.
[22] 赵娟. 京尼平苷对鱼藤酮诱导的原代神经细胞损伤的保护作用[D]. 太原:山西医科大学, 2014. Zhao Juan. The protective effect of geniposide on primary cultured nerve cell damage induced by rotenone[D]. Taiyuan:Shanxi Medical Universi-ty, 2014.
[23] Li F, Dong H X, Gong Q H, et al. Icariin decreases both APP and Aβ lev-els and increases neurogenesis in the brain of Tg2576 mice[J]. Neurosci-ence, 2015, 304:29-35.
[24] Caccamo A, De Pinto V, Messina A, et al. Genetic reduction of mammali-an target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression sig-nature[J]. The Journal of Neuroscience, 2014, 34(23):7988-7998.
[25] Durk M R, Han K, Chow E C Y, et al. 1α, 25-Dihydroxyvitamin D3 re-duces cerebral amyloid-β accumulation and improves cognition in mouse models of Alzheimer's disease[J]. The Journal of Neuroscience, 2014, 34(21):7091-7101.
[26] Omura T, Omura K, Tedeschi A, et al. Robust axonal regeneration oc-curs in the injured CAST/Ei mouse CNS[J]. Neuron, 2015, 86(5):1215-1227.
[27] Check E. Nerve inflammation halts trial for Alzheimer's drug[J]. Nature, 2002, 415(6871):462-462.
[28] 尹雅菲, 童贻刚, 庆宏. 阿尔茨海默症的诊断与治疗研究进展[J]. 生物技术通讯, 2013(2):276-279. Yin Yafei, Tong Yigang, Qing Hong. Progress in the treatment of Al-zheimer's Disease[J]. Letters in Biotechnology, 2013(2):276-279.
[29] Montagne A, Barnes S R, Sweeney M D, et al. Blood-brain barrier break-down in the aging human hippocampus[J]. Neuron, 2015, 85(2):296-302.
